Arcturus Therapeutics Holdings (ARCT) Cash from Investing Activities (QoQ) (2018 - 2026)
Arcturus Therapeutics Holdings (ARCT) Cash from Investing Activities (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Arcturus Therapeutics Holdings | 165.13 Mn | -46.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -61.36% |
| Dec 31, 2025 | 148.62% |
| Sep 30, 2024 | 75.61% |
| Jun 30, 2024 | -36.67% |
| Mar 31, 2024 | 72.57% |
| Dec 31, 2023 | 10.81% |
| Sep 30, 2023 | -177.12% |
| Jun 30, 2023 | 48.77% |
| Mar 31, 2023 | 81.85% |
| Dec 31, 2022 | -74.15% |
| Sep 30, 2022 | -678.31% |
| Jun 30, 2022 | 117.91% |
| Mar 31, 2022 | -88.82% |
| Dec 31, 2021 | 36.69% |
| Sep 30, 2021 | -337.13% |
| Jun 30, 2021 | -242.37% |
| Mar 31, 2021 | 83.07% |
| Dec 31, 2020 | -60.60% |
| Sep 30, 2020 | 7.46% |
| Jun 30, 2020 | -230.28% |